Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility - Competitive Process

Tender description

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf<br/>of NHS England (referred to as the Authority), is inviting suitably qualified and<br/>experienced providers to respond to this Competitive Process for the provision of a<br/>Fertility service for preservation and use of reproductive tissue for service users who<br/>cannot store mature eggs/sperm who are at high/very high risk of infertility.<br/>* Lot 1 - Hub - (2 providers - 1 provider to cover North East, North West, Yorkshire &<br/>Humber and Midlands NHS Regions and 1 provider to cover East of England, London,<br/>South East and South West NHS Regions)<br/>* Lot 2 - Tissue Establishment - (2 providers - 1 provider to cover North East, North West,<br/>Yorkshire & Humber and Midlands NHS Regions and 1 provider to cover East of England,<br/>London, South East and South West NHS Regions)<br/>* Lot 3 - Fertility & Endocrine Restoration Services (2 providers - 1 provider to cover North<br/>East, North West, Yorkshire & Humber and Midlands NHS Regions and 1 provider to<br/>cover East of England, London, South East and South West NHS Regions)<br/>The contract start date is 1st April 2026 with a service commencement date of no later than1st July 2026.<br/>The contract period is 5 years with Commissioners having the option to extend for up to a<br/>further 58 months.<br/>Please note that the contract value included in II.1.7.1 is the estimated contract value that was included in the contract notice and was based on the total contract period including optional extensions. The values included in the ‘suppliers awarded’ sections of individual notices are the intended contract award values over the initial contract period only and excludes any optional extension periods. All values are inclusive of VAT. Lot 1: Lot 1 - Hub As detailed in the Competitive Process documentation.<br/>This is a Provider Selection Regime (PSR)Contract Notice. The awarding of this contract<br/>is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For<br/>the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.<br/>The decision maker of the award will be: NHS England - National Commissioning Group.<br/>The intention is to award contracts using the Competitive Process.<br/>The announcement by Government, on 13th March 2025, will not disrupt commissioning<br/>and contracting of this service. NHS England continues to exist as a statutory body for<br/>now. The dissolution of NHS England during the term of the contract will be subject to an<br/>act of Parliament and its undertakings will be transferred as appropriate. As and when<br/>NHS England is dissolved, commissioning responsibilities will be transferred to an<br/>alternative commissioning authority. At this time, the General Condition 12 ‘Assignment<br/>and Sub-Contracting’ of the NHS Standard Contract, as per the obligations of the<br/>commissioner, will set out the terms and conditions under which the contract will be<br/>transferred or assigned to the relevant commissioning authority.<br/>Please note the value included at V.2.4.1 is the initial Lot 1 contract value over the whole contract period including extensions. The values included under the individual awarded providers are for the initial contract period of 5 years only. Additional information: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight on Tuesday 10th February 2026. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the competitive process of the PSR. Written representations should be sent to anna.salt@nhs.net ensuring the following details are referenced:<br/>Project reference: C371608<br/>Project title: Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility - Competitive Process<br/>This decision has been made as per NHS England governance processes, by the National Commissioning<br/>Group on 20th January 2026. No conflicts of Interest were identified amongst decision<br/>makers.<br/>Key Criteria were weighted as follows:<br/>Lot 1:<br/>• Quality & Innovation 27%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 22%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 8%<br/>• Social Value 10%<br/><br/>Lot 2:<br/>• Quality & Innovation 42%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 13%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 2%<br/>• Social Value 10%<br/><br/>Lot 3: <br/>• Quality & Innovation 33%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 22%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 2%<br/>• Social Value 10% Lot 2: Lot 2 - Tissue Establishment As detailed in the Competitive Process documentation.<br/>This is a Provider Selection Regime (PSR)Contract Notice. The awarding of this contract<br/>is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For<br/>the avoidance of doubt, the provisions of the Public<br/>Contracts Regulations 2015 do not apply to this award.<br/>The decision maker of the award will be: NHS England - National Commissioning Group.<br/>The intention is to award contracts using the Competitive Process.<br/>The announcement by Government, on 13th March 2025, will not disrupt commissioning<br/>and contracting of this service. NHS England continues to exist as a statutory body for<br/>now. The dissolution of NHS England during the term of the contract will be subject to an<br/>act of Parliament and its undertakings will be transferred as appropriate. As and when<br/>NHS England is dissolved, commissioning responsibilities will be transferred to an<br/>alternative commissioning authority. At this time, the General Condition 12 ‘Assignment<br/>and Sub-Contracting’ of the NHS Standard Contract, as per the obligations of the<br/>commissioner, will set out the terms and conditions under which the contract will be<br/>transferred or assigned to the relevant commissioning authority.<br/>Please note the value included at V.2.4.1 is the initial Lot 2 contract value over the whole contract period including extensions. The values included under the individual awarded providers are for the initial contract period of 5 years only. Additional information: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight on Tuesday 10th February 2026. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the competitive process of the PSR. Written representations should be sent to anna.salt@nhs.net ensuring the following details are referenced:<br/>Project reference: C371608<br/>Project title: Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility - Competitive Process<br/>This decision has been made as per NHS England governance processes, by the National Commissioning<br/>Group on 20th January 2026. No conflicts of Interest were identified amongst decision<br/>makers.<br/>Key Criteria were weighted as follows:<br/>Lot 1:<br/>• Quality & Innovation 27%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 22%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 8%<br/>• Social Value 10%<br/><br/>Lot 2:<br/>• Quality & Innovation 42%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 13%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 2%<br/>• Social Value 10%<br/><br/>Lot 3:<br/>• Quality & Innovation 33%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 22%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 2%<br/>• Social Value 10% Lot 3: Lot 3 - Fertility & Endocrine Restoration Service As detailed in the Competitive Process documentation.<br/>This is a Provider Selection Regime (PSR)Contract Notice. The awarding of this contract<br/>is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For<br/>the avoidance of doubt, the provisions of the Public<br/>Contracts Regulations 2015 do not apply to this award.<br/>The decision maker of the award will be: NHS England - National Commissioning Group.<br/>The intention is to award contracts using the Competitive Process.<br/>The announcement by Government, on 13th March 2025, will not disrupt commissioning<br/>and contracting of this service. NHS England continues to exist as a statutory body for<br/>now. The dissolution of NHS England during the term of the contract will be subject to an<br/>act of Parliament and its undertakings will be transferred as appropriate. As and when<br/>NHS England is dissolved, commissioning responsibilities will be transferred to an<br/>alternative commissioning authority. At this time, the General Condition 12 ‘Assignment<br/>and Sub-Contracting’ of the NHS Standard Contract, as per the obligations of the<br/>commissioner, will set out the terms and conditions under which the contract will be<br/>transferred or assigned to the relevant commissioning authority.<br/>Please note the value included at V.2.4.1 is the initial Lot 3 contract value over the whole contract period including extensions. The values included under the individual awarded providers are for the initial contract period of 5 years only. Additional information: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight on Tuesday 10th February 2026. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the competitive process of the PSR. Written representations should be sent to anna.salt@nhs.net ensuring the following details are referenced:<br/>Project reference: C371608<br/>Project title: Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility - Competitive Process<br/>This decision has been made as per NHS England governance processes, by the National Commissioning<br/>Group on 20th January 2026. No conflicts of Interest were identified amongst decision<br/>makers.<br/>Key Criteria were weighted as follows:<br/>Lot 1:<br/>• Quality & Innovation 27%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 22%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 8%<br/>• Social Value 10%<br/><br/>Lot 2:<br/>• Quality & Innovation 42%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 13%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 2%<br/>• Social Value 10%<br/><br/>Lot 3:<br/>• Quality & Innovation 33%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 22%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 2%<br/>• Social Value 10%